AtriCure (ATRC) Shares Outstanding (Diluted Average) (2019 - 2026)

AtriCure (ATRC) has 8 years of Shares Outstanding (Diluted Average) data on file, last reported at $49.0 million in Q1 2026.

• Quarterly Shares Outstanding (Diluted Average) rose 3.49% year-over-year to $49.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $49.0 million (up 3.49% YoY) and the FY2025 annual result came in at $47.8 million, up 1.67% from the prior year.
• Shares Outstanding (Diluted Average) grew to $49.0 million in Q1 2026 per ATRC's latest filing, from $47.8 million in the prior quarter.
• Across five years, Shares Outstanding (Diluted Average) topped out at $49.0 million in Q1 2026 and bottomed at $45.5 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $46.7 million (2024), against an average of $46.7 million.
• The widest annual swing landed in 2022, when Shares Outstanding (Diluted Average) retreated 0.68%; it then increased 3.49% in 2026.
• Tracing ATRC's Shares Outstanding (Diluted Average) over 5 years: stood at $45.7 million in 2022, then gained by 1.24% to $46.3 million in 2023, then rose by 1.42% to $47.0 million in 2024, then grew by 1.67% to $47.8 million in 2025, then gained by 2.71% to $49.0 million in 2026.
• Per Business Quant, the three latest ATRC Shares Outstanding (Diluted Average) figures stand at $49.0 million (Q1 2026), $47.8 million (Q4 2025), and $47.7 million (Q3 2025).

Peer Comparison